ASNC

This channel contains news about the American Society of Nuclear Cardiology (ASNC), including coverage of its annual meeting and links to recently released practice guidelines. ASNC is a leading resource for the subspecialty of cardiac nuclear imaging (also called molecular imaging). Cardiac imaging with either PET or SPECT is primarily used for myocardial perfusion imaging (MPI), which shows area of areas of reduced blood flow due to ischemia or infarct. 

News | Coronavirus (COVID-19) | Dave Fornell, Editor

April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear ...

Home April 03, 2020
Home
Rupa Sanghani, M.D., FASNC, director of Rush's nuclear cardiology and stress laboratory, explaining to ASNC 2019 attendees how Rush implemented its program during a tour of its PET-CT suite.
Feature | PET-CT | Dave Fornell, Editor

As hospital imaging departments look to replace aging nuclear scanners with updated technology, many are asking if ...

Home February 19, 2020
Home
Why Structured Reporting is Needed in Cardiology
Feature | Cardiovascular Information Systems (CVIS)

Cardiology was already heavily data driven, where clinical practice is driven by clinical study data, but mining a ...

Home January 23, 2020
Home
This is 4MD’s cardiac nuclear imaging analysis software, shown here integrated with a ScImage cardiovascular information system (CVIS). Both companies displayed on the expo floor at ASNC 2019. The software creates a single page report seen here. PET perfusion imaging was a big topics at the conference. #ASNC #ASNC19 #ASNC2019
Feature | Nuclear Imaging | Dave Fornell, Editor

There were a few key takeaways from the American Society of Nuclear Cardiology (ASNC) 2019 annual meeting in September ...

Home November 22, 2019
Home
Videos | Nuclear Imaging

Rob Beanlands, M.D., FASNC, 2019 American Society of Nuclear Cardiology (ASNC) president, shares a couple trends he sees ...

Home November 07, 2019
Home
Videos | Nuclear Imaging

Robert C. Hendel, M.D., explains some of the new cardiac radiotracers in the pipeline that were discussed in sessions at ...

Home November 06, 2019
Home
Videos | PET-CT

Rupa Sanghani, M.D., FASNC, associate professor, Rush Medical College, director of nuclear cardiology and stress ...

Home October 30, 2019
Home
Videos | Cardiac Diagnostics

Clyde Yancy, M.D., MSc, cardiology chief and vice dean for diversity and inclusion at Northwestern University, Feinberg ...

Home October 29, 2019
Home
News | Cardiac Imaging

September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along ...

Home September 09, 2019
Home
News | Radiopharmaceuticals and Tracers

August 2, 2019 — The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) ...

Home August 02, 2019
Home
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. The image shows how SPECT allows the reader to distinguish between blood pool activity and radiotracer uptake.
Feature | Nuclear Imaging | Christopher A. Hanson M.D., and Jamieson M. Bourque M.D., MHS

Cardiac amyloidosis is a highly morbid and underdiagnosed infiltrative cardiomyopathy that is characterized by the ...

Home July 22, 2019
Home
Blog | Nuclear Imaging

This week, cardiologists learned for the first time they have been examining black holes for decades and did not know it ...

Home April 12, 2019
Home
Videos | Nuclear Imaging

Raza Alvi, M.D., a research fellow in radiology at Massachusetts General Hospital, has been involved in a study of a ...

Home March 22, 2019
Home
Subscribe Now